Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Astrazeneca Plc ADR (AZN)
Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 206,326,640
  • Shares Outstanding, K 3,100,325
  • Annual Sales, $ 44,351 M
  • Annual Income, $ 3,288 M
  • 60-Month Beta 0.52
  • Price/Sales 4.61
  • Price/Cash Flow 12.79
  • Price/Book 5.42
Trade AZN with:

Options Overview Details

View History
  • Implied Volatility 21.29% ( -4.25%)
  • Historical Volatility 21.75%
  • IV Percentile 28%
  • IV Rank 24.34%
  • IV High 31.19% on 10/16/23
  • IV Low 18.11% on 08/01/23
  • Put/Call Vol Ratio 0.68
  • Today's Volume 42,092
  • Volume Avg (30-Day) 9,285
  • Put/Call OI Ratio 1.38
  • Today's Open Interest 141,479
  • Open Int (30-Day) 127,950

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.74
  • Number of Estimates 5
  • High Estimate 0.80
  • Low Estimate 0.71
  • Prior Year 0.69
  • Growth Rate Est. (year over year) +7.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.70 +2.95%
on 02/08/24
69.91 -9.14%
on 01/11/24
-5.69 (-8.22%)
since 01/08/24
3-Month
61.70 +2.95%
on 02/08/24
69.91 -9.14%
on 01/11/24
-0.01 (-0.02%)
since 11/08/23
52-Week
61.70 +2.95%
on 02/08/24
76.56 -17.03%
on 04/25/23
-0.84 (-1.31%)
since 02/08/23

Most Recent Stories

More News
S&P 500 and Nasdaq 100 Post Record Highs on Solid Earnings

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,997.91 (+0.06%)
SPY : 498.32 (+0.04%)
$DOWI : 38,726.33 (+0.13%)
DIA : 387.35 (+0.18%)
$IUXX : 17,783.17 (+0.16%)
QQQ : 432.79 (+0.19%)
RL : 171.85 (+16.79%)
MPWR : 737.07 (+14.20%)
DIS : 110.54 (+11.50%)
NWS : 27.01 (+6.76%)
TPR : 42.99 (+6.54%)
WYNN : 106.11 (+6.29%)
AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript

AZN earnings call for the period ending December 31, 2023.

AZN : 63.52 (-4.55%)
Higher Bond Yields Weigh on Stocks But Chip Stocks Provide Support

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.13%. Stock...

$SPX : 4,997.91 (+0.06%)
SPY : 498.32 (+0.04%)
$DOWI : 38,726.33 (+0.13%)
DIA : 387.35 (+0.18%)
$IUXX : 17,783.17 (+0.16%)
QQQ : 432.79 (+0.19%)
PYPL : 56.13 (-11.24%)
EG : 354.56 (-7.65%)
FLT : 265.12 (-9.20%)
SPGI : 436.63 (-5.02%)
BWA : 31.48 (-6.95%)
AZN : 63.52 (-4.55%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

ONCY : 1.0200 (+14.21%)
ONC.TO : 1.37 (+13.22%)
PFE : 27.57 (+0.04%)
ARVN : 48.28 (+1.68%)
OLMA : 15.25 (-0.72%)
AZN : 63.52 (-4.55%)
History Says the Nasdaq Will Keep Soaring in 2024. Here's the Surprising Megacap Stock Wall Street Thinks Will Be the Biggest Winner.

Hint: It's not Alphabet, Amazon, Apple, Meta Platforms, Microsoft, Nvidia, or Tesla.

AMZN : 169.84 (-0.40%)
AAPL : 188.32 (-0.58%)
MSFT : 414.11 (+0.01%)
NVDA : 696.41 (-0.65%)
COMP : 3.76 (+2.17%)
TSLA : 189.56 (+1.06%)
AZN : 63.52 (-4.55%)
Top 3 Smart Pharma Picks for Good Investments

As global medical needs and technology evolve, the pharmaceutical industry is expected to thrive. Therefore, fundamentally strong pharma stocks Eli Lilly (LLY), AstraZeneca (AZN) and GSK (GSK) might be...

AZN : 63.52 (-4.55%)
GSK : 41.82 (-0.48%)
LLY : 735.68 (+1.42%)
2 Mega-Cap Pharma Stocks to Buy for More Upside

Here's what Wall Street says about these two pharma giants with footprints in the growing anti-obesity market, and what the upside forecast is for these standout stocks heading into 2024.

NVO : 118.39 (-0.23%)
AZN : 63.52 (-4.55%)
3 No-Brainer Stocks to Buy With $500 Right Now

A reasonably modest amount of money can go a long way when it's put to work in industry-leading businesses.

COMP : 3.76 (+2.17%)
GOOGL : 145.91 (+0.25%)
GOOG : 147.22 (+0.37%)
AZN : 63.52 (-4.55%)
XOM : 103.97 (+1.71%)
3 Magnificent Stocks to Buy and Hold Forever

Many investors will want to consider owning these stocks for a long time.

AZN : 63.52 (-4.55%)
REGN : 946.43 (+0.85%)
VRTX : 423.06 (+0.95%)
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs

NetworkNewsWire Editorial Coverage : Already proven to be a revolutionary treatment for type 2 diabetes and weight loss, glucagon-like peptide-1 (GLP-1) agonists now appear to have a multitude of potential...

LEXX : 1.9000 (-4.04%)
PFE : 27.57 (+0.04%)
MRK : 126.61 (-0.67%)
AZN : 63.52 (-4.55%)
NVO : 118.39 (-0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition...

See More

Key Turning Points

3rd Resistance Point 66.57
2nd Resistance Point 65.23
1st Resistance Point 64.38
Last Price 63.52
1st Support Level 62.18
2nd Support Level 60.84
3rd Support Level 59.99

See More

52-Week High 76.56
Fibonacci 61.8% 70.88
Fibonacci 50% 69.13
Fibonacci 38.2% 67.38
Last Price 63.52
52-Week Low 61.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar